Nerviano Medical Sciences (NervianoMS) Announces New License Agreement
NERVIANO, Italy--(BUSINESS WIRE)--Nerviano Medical Sciences (NMS), the largest pharmaceutical R&D facility in Italy and one of the leading oncology-focused, integrated discovery and development companies in Europe, today announced a license agreement with Novartis.